The 2024 SFCR of CNP Vita (CNP UniCredit Vita S.p.A.) shows the Italian life insurer’s Solvency II ratio edging up from 413% at year-end 2023 to 414% in 2024, as eligible own funds grew to EUR 1.096 billion; their highest level across the nine years of Solvency II public disclosures.

SOURCE: Solvency II Wire Data

Own funds rose by €100m over the year while the SCR increased by €23m. Although the own funds grew significantly more than the SCR this year, the ratio remained relatively stable. The more dramatic shift came in 2023, when a sharp fall in the SCR (from €306m to €241m) alongside modest own-funds growth pushed the ratio up by more than 114 percentage points in a single year.

SOURCE: Solvency II Wire Data

The capital base is wholly composed of Tier 1 unrestricted capital. Small amounts of Tier 1 restricted and Tier 3 capital appeared in the early years of Solvency II implementation (2016–2018), but since 2019 the eligible own funds stack has been entirely unrestricted Tier 1 — the highest-quality category under the Solvency II framework.

Full detail on the composition of eligible own funds and the SCR calculation is available on Solvency II Wire Data.